Colgate-Palmolive has settled a lawsuit accusing the company of selling asbestos-laced body powders.
By Laurence Banville
Colgate-Palmolive settled a talcum powder lawsuit on November 10, 2017, resolving claims that the company's talc-based body powders were laced with asbestos, a deadly mineral and the only confirmed cause of mesothelioma. The complaint was filed by a Pennsylvania woman who developed the aggressive cancer, which affects tissue lining, after using the cosmetic product Cashmere Bouquet for over 20 years, Bloomberg reports. The terms of the deal have not been made public.
Talc Litigation Extends To Mesothelioma ClaimsTens of thousands of women have filed talcum powder suits against Johnson & Johnson, saying the conglomerate failed to warn the public of a link between talc-based products and ovarian cancer. But a growing number of complaints now mention the risk of mesothelioma, drawing on reports from mines, beginning during the 1970s, which appear to confirm that some of Johnson & Johnson's talc supply may have been contaminated by asbestos.
One of these claims, Herford v. Johnson & Johnson, is now being heard by a Los Angeles jury in the Superior Court for the State of California, according to Insurance Journal. The trial began over a month ago, on October 6, 2017, but a mistrial was called when the plaintiff referenced the potential link between talc and ovarian cancer during testimony. The trial, which began anew with another jury on October 19, 2017, is still ongoing.
After $13M Verdict, Colgate Begins To SettleAnd while the mesothelioma allegations may be new to Johnson & Johnson, Colgate-Palmolive has been fielding similar ones for years. In 2015, a jury in California ordered the company to pay $13 million in damages to a woman who was diagnosed with mesothelioma after using Cashmere Bouquet.
Today, Colgate-Palmolive is facing over 170 lawsuits filed by mesothelioma patients who claim the company sold body powders that contained asbestos, many of which stretch back to the 1960s and '70s for their exposure data. The manufacturer has resolved 43 similar cases so far in 2017, it said in a filing with the US Securities and Exchange Commission.